| Short Description : | Recombinant-canine IFN-gamma/IFNG-No-Tag protein was developed from e.coli and has a target region of No-Tag. For use in research applications. |
| Applications: | SDS-PAGE |
| Host: | E.coli |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Concentration: | 1 mg/mL |
| Formulation: | Liquid in phosphate-Buffered Saline (pH 7.4) containing 10% Glycerol |
| Storage Instruction: | For short term storage, keep at +2C to +8C for up to 1 week. For long term storage, aliquot and store at-20C, and avoid repeat freeze-thaw cycles. |
| Endotoxin: | < 1 EU per 1ug of protein (determined by LAL method) |
| Accession Number: | NP_001003174 |
| Immunogen: | Canine |
| Immunogen Region: | 24-166aa |
| Immunogen Sequence: | MQAMFFKEIE NLKEYFNASN PDVSDGGSLF VDILKKWREE SDKTIIQSQI VSFYLKLFDN FKDNQIIQRS MDTIKEDMLG KFLNSSTSKR EDFLKLIQIP VNDLQVQRKA INELIKVMND LSPRSNLRKR KRSQNLFRGR RASK |
| Background | IFNG also known as, Interferon gamma is a member of the type 2 interferon family. This protein is a soluble cytokine with antiviral, immunoregulatory and anti-tumor properties and is a potent activator of macrophages. Mutations in this gene are associated with aplastic anemia. Recombinant Canine IFNG was expressed in E. coli and purified by using conventional chromatography techniques. |
Information sourced from Uniprot.org